<DOC>
	<DOCNO>NCT00733642</DOCNO>
	<brief_summary>The purpose study determine whether single dos PF-04360365 safe well tolerated patient Alzheimer 's Disease .</brief_summary>
	<brief_title>Single Dose Escalation Study PF-04360365 In Subjects With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Male female ( nonchild bear potential ) subject ages ≥50 year age . Diagnosis probable AD ( mild moderate severity ) , consistent criterion : NINCDSAlzheimer 's Disease Related Disorders Association ( ADRDA ) DSMIVTR . MMSE score 1626 inclusive . RosenModified Hachinski Ischemia Score ≤4 . On stable dose background cholinesterase inhibitor memantine least 60 day prior dose . Diagnosis history dementia neurodegenerative disorder . Diagnosis history clinically significant cerebrovascular disease . Specific finding magnetic resonance imaging ( MRI ) ; cortical infarct , micro hemorrhage , multiple white matter lacunes . History allergic anaphylactic reaction .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>antibody amyloid Alzheimer 's Disease AD</keyword>
</DOC>